MAIA Biotechnology, Inc. ( ($MAIA) ) has shared an announcement. On November 20, 2025, MAIA Biotechnology announced that its CEO, Vlad Vitoc, ...

Company starts enrollment in Romania for Phase 2 THIO-101 Part C study of ateganosine as a treatment for advanced non-small ...

To tackle critical national security challenges, drive innovation and support U.S. global competitiveness, Indiana University ...

The Indian Venture and Alternate Capital Association (IVCA), the apex body representing India's alternate capital ecosystem, ...

MAIA Biotechnology (MAIA) announced a presentation by CEO Vlad Vitoc, M.D. at Smart Diaspora 2025, a conference dedicated to advancing oncology ...

The Biomanufacturing Excellence Act creates a national Center of Excellence to drive innovation in biopharmaceutical manufacturing.

Women are being warned against buying at-home ‘menopause tests’, as experts voice concerns about how those entering this ...

UC Davis nematologists, including Valerie Williamson, professor emerita in the Department of Plant Pathology, and associate ...

Despite Washington’s long-standing warnings to other nations against accepting loans from Chinese state banks, the United ...

Jyong Biotech Ltd. (Nasdaq: MENS) (the 'Company” or 'Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated ...

PMB-CT01 is a first-in-class BAFF-R–targeted autologous CAR T cell therapy. BAFF-R is expressed almost exclusively on B cells and is essential for B-cell survival, reducing the likelihood of ...

On November 17, 2025, Biohaven's Chief Accounting Officer, George Clark, acquired 17,000 shares of company stock. The Chief ...